Adenosine receptors and their ligands

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 362, Issue 4-5, 2000, Pages 382-391

  Klotz, K N ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

A(2A); A(2B); A1; A3; Adenosine; Adenosine receptors; Agonist; Antagonist; High affinity; Human; Ligand; Radioligand; Selectivity

Indexed keywords

2 (2 FURYL) 5 [3 (4 METHOXYPHENYL)UREIDO] 8 PROPYLPYRAZOLO[4,3 E] 1,2,4 TRIAZOLO[1,5 C]PYRIMIDINE; 2 (3 HYDROXY 3 PHENYL)PROPYN 1 YLADENOSINE 5' N ETHYLURONAMIDE; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 2 CHLORO 6 N CYCLOPENTYLADENOSINE; 2 HEXYN 1 YLADENOSINE 5' N ETHYLURONAMIDE; 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 6 N (3 IODOBENZYL)ADENOSINE 5' N METHYLURONAMIDE; 6 N (4 AMINOBENZYL)ADENOSINE 5' N METHYLURONAMIDE; 6 N CYCLOPENTYLADENOSINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 9 CHLORO 2 (2 FURYL) 5 [(PHENYLACETYL)AMINO][1,2,4]TRIAZOLO[1,5 C]QUINAZOLINE; 9 CHLORO 2 (2 FURYL) 5 PHENYLACETYLAMINO 1,2,4 TRIAZOLO[1,5 C]QUINAZOLINE; 9 CHLORO 2 (2 FURYL) 5,6 DIHYDRO 5 IMINO 1,2,4 TRIAZOLO[2,3 C]QUINAZOLINE; ADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; CAFFEINE; CYCLOHEXYLADENOSINE; LIGAND; MRS 1334; MRS 1353; PHENYLISOPROPYLADENOSINE; THEOPHYLLINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BINDING AFFINITY; DRUG ACTIVITY; DRUG POTENCY; DRUG STRUCTURE; RECEPTOR BINDING; REGULATORY MECHANISM; REVIEW;

ANIMALS; HUMANS; LIGANDS; RADIOLIGAND ASSAY; RECEPTORS, PURINERGIC P1; STRUCTURE-ACTIVITY RELATIONSHIP; XANTHINE;

EID: 0033756079     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002100000315     Document Type: Review

References (65)

1. Functional characterization of the A(2b) adenosine receptor in NIH 3T3 fibroblasts
2. 3H]NECA in rat striatal membranes
3. 1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes
4. New substituted 9-alkylpurines as adenosine receptor ligands
5. Adenosine receptor agonists: Synthesis and biological evaluation of 1-deaza analogues of adenosine
6. 2 adenosine receptors
7. Adenosine receptors: Targets for future drugs
8. Metabolic flux rates of adenosine in the heart
9. 3H]-SCH 58261
10. The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart
11. Adenosine A(2B) receptors: A novel therapeutic target in asthma?
12. Adenosine A1 receptors in mammalian brain: Species differences in their interactions with agonists and antagonists
13. VI: Nomenclature and classification of purinoceptors
14. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use
15. Structure and function of adenosine receptors
16. 3-selective adenosine agonists
17. 2 selective adenosine receptor agonist with preferential hypotensive activity
18. 3-adenosine receptors: Design of selective ligands and therapeutic prospects
19. 2 receptors in rat brain
20. 3H]ZM 241385 as a radioligand at recombinant human A(2B) adenosine receptors
21. 3-adenosine receptors
22. 3 adenosine receptor antagonists
23. 3 receptor subtype
24. Acyl-hydrazide derivatives of a xanthine carboxylic congener (XCC) as selective antagonists at human A(2B) adenosine receptors
25. 1 adenosine receptors in rat brain membranes. Evidence for histidine in different domains of the ligand binding site
26. 1 adenosine receptors
27. 1 adenosine receptors in brain from different species by radioligand binding and photoaffinity labelling
28. Comparative pharmacology of human adenosine receptor subtypes - Characterization of stably transfected receptors in CHO cells
29. 3 adenosine receptors
30. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A(2a) receptor
31. 3 receptors: Pharmacological properties, species differences and receptor functions
32. Characterization of human A(2B) adenosine receptors: Radioligand binding, Western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells
33. 1 adenosine receptors
34. 1 adenosine receptors
35. 6-cyclohexyladenosine: An adenosine derivative with antagonist properties at adenosine receptors
36. Subclasses of external adenosine receptors
37. Adenosine receptor antagonists: Structure and potential therapeutic applications
38. Synthesis and structure-activity relationships of 3,7-dimethyl-1-propargylxanthine derivatives, A(2A)-selective adenosine receptor antagonists
39. 8-(Sulfostyryl)xanthines: Water-soluble A(2A)-selective adenosine receptor antagonists
40. A(2A)-selective adenosine receptor antagonists: Development of water-soluble prodrugs and a new tritiated radioligand
41. 3 adenosine receptor
42. Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors
43. 125I-4-(2-[7-amino-2-{2-furyl}{1,2,4}triazolo{2,3-a}{1,3,5}triazin -5-yl-amino]ethyl)phenol, a high affinity antagonist radioligand selective for the A(2a) adenosine receptor
44. Molecular cloning and expression of an adenosine A2b receptor from human brain
45. The in vitro pharmacology of ZM241385, a potent, non-xanthine A(2a) selective adenosine receptor antagonist
46. Adenosine receptors: New opportunities for future drugs
47. Receptors for purines and pyrimidines
48. 1 receptors?
49. 3 adenosine receptor
50. The effect of adenosine and adenine nucleotides on the cyclic adenosine 3',5'-phosphate content of guinea pig cerebral cortex slices
51. Water-soluble phosphate prodrugs of 1-propargyl-8-styrylxanthine derivatives, A(2A)-selective adenosine receptor antagonists
52. 6-phenylisopropyladenosine
53. Search for new purine- and ribose-modified adenosine analogues as selective agonists and antagonists at adenosine receptors
54. 2 binding sites in striatal membranes from mammalian brain
55. Antagonism of adenosine A(2A) receptors underlies the behavioral activating effect of caffeine and is associated with reduced expression of messenger RNA for NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens
56. 1 adenosine receptor
57. Adenosine inhibits the accumulation of cyclic AMP in cultured brain cells
58. Adenosine regulates, via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells
59. Ribose-modified adenosine analogues as potential partial agonists for the adenosine receptor
60. 1 receptor
61. 3 receptor
62. 3 adenosine receptors
63. Biochemical characterization of the triazoloquinazoline, CGS 15943, a novel, non-xanthine adenosine antagonist
64. Molecular cloning and characterization of an adenosine receptor: The A3 adenosine receptor
65. The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A(2a) adenosine receptor antagonist